US · Healthcare · Medical Instruments & Supplies
EPS came in at 3.23 against a street estimate of 3.14 — a beat of 2.9%.
Analysts rate Becton Dickinson and Company a buy (7 buy, 9 hold, 0 sell out of 16) with an average price target of $195.67.
CONFIDENT BD delivered Q3 FY26 revenue of $5B (+4.4%), adjusted EPS of $3.23 (+4.9%), ahead of expectations. Growth platforms (biologics, APM, PureWick, tissue regeneration) driving momentum. Raised FY26 EPS guidance midpoint. Alaris and China headwinds playing out as expected. Q3 FY26 U.S. driving strength in MDS, specimen management, APM. China headwinds concentrated in vaccines (stabilizing) and general market dynamics; expected to shrink to 3-4% of NBD revenue. Analysts probed sustainability of Q3 strength, competitive share gains, and Q4 deceleration. Management emphasized growth platforms are structural (not onetime), commercial changes embedded, and Alaris decline is the primary Q4/FY27 headwind—fully expected and offset by pricing/productivity. 2026-08-06…
Full summary in the app.
| Fund | Stake |
|---|---|
| Arnhold & S. Bleichroeder Advisers, LLC | 10.14% |
| BlackRock Inc | 9.60% |
| Vanguard Capital Management, LLC | 6.79% |
| Vanguard Portfolio Management, LLC | 5.62% |
| State Street Corp | 5.07% |
| Amvescap Plc. | 3.74% |
| T. Rowe Price Investment Management,Inc. | 3.56% |
| Massachusetts Financial Services Company | 3.34% |
| Document | Date |
|---|---|
| Quarterly report · Q3 FY2026 BECTON, DICKINSON AND COMPANY Form 10-Q for Quarter Ended June 30, 2026 --- HEADLINE NUMBERS • Q3 2026 Revenue: $4,983 million (vs. $4,726 million | 2026-08-06 |
| Results announced · Q4 FY2026 BD (BECTON, DICKINSON AND COMPANY) - Q3 FISCAL 2026 SUMMARY HEADLINE NUMBERS • Q3 Revenue: $4,983 million, up 5.4% as reported (4.4% currency-neutra | 2026-08-06 |
| Board / officer change · Q4 FY2026 BECTON, DICKINSON AND COMPANY (BDX) - 8-K FILING SUMMARY Date: July 19-22, 2026 --- BUSINESS & SEGMENT HIGHLIGHTS • Michael D. Garrison, Executive | 2026-07-22 |
| Reg FD disclosure · Q3 FY2026 BECTON, DICKINSON AND COMPANY (BDX) – FORM 8-K SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • BD resumed U.S. shipments of ChloraPrep™ (antiseptic skin pre | 2026-05-29 |
| Material agreement · Q3 FY2026 BECTON, DICKINSON AND COMPANY (BDX) – FORM 8-K SUMMARY HEADLINE NUMBERS • BD's Luxembourg subsidiary (Becton Dickinson Euro Finance S.à r.l.) issued | 2026-05-20 |
| Quarterly report · Q2 FY2026 BECTON, DICKINSON AND COMPANY — Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Revenues (Q2 2026): $4,714 million, up 5.2% from $4,480 million (Q2 2025) • | 2026-05-07 |
| Quarterly report · Q1 FY2026 BECTON, DICKINSON AND COMPANY (BDX) - Q1 FY2026 10-Q SUMMARY HEADLINE NUMBERS • Revenues (Q1 FY2026): $5,252 million vs. $5,168 million prior year ( | 2026-02-09 |
| Proxy statement · Q1 FY2026 BECTON, DICKINSON AND COMPANY (BD) — PROXY STATEMENT SUMMARY CEO TOTAL COMPENSATION & CHANGE • CEO Tom Polen's 2025 total direct compensation compri | 2025-12-18 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $1.05 / share ex-date Sep 9, 2026 · pay Sep 30, 2026 | 2026-09-09 |
| Dividend | $1.05 / share ex-date Jun 9, 2026 · pay Jun 30, 2026 | 2026-06-09 |
| Dividend | $1.05 / share ex-date Mar 10, 2026 · pay Mar 31, 2026 | 2026-03-10 |
| Split | 1272 : 1000 effective Feb 10, 2026 | 2026-02-10 |
| Dividend | $0.83 / share ex-date Dec 8, 2025 · pay Dec 31, 2025 | 2025-12-08 |
| Dividend | $0.82 / share ex-date Sep 8, 2025 · pay Sep 30, 2025 | 2025-09-08 |
| Announcement | Date |
|---|---|
| Company to repurchase $2B shares and repay $2B debt from spinoff proceeds Becton, Dickinson and Company (BD) completed a spin-off transaction on February 6, 2026, separating a business unit into SpinCo. As part of this separation, BD received a $4 billion cash dis | 2026-02-09 |
| Announced reverse morris trust combination with Waters Corporation Becton, Dickinson and Company (BD) filed paperwork related to its planned spinoff of its Biosciences and Diagnostic Solutions business through a Reverse Morris Trust (RMT) transaction with W | 2026-02-05 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Becton Dickinson and Company — free to start.
Google PlayApp StoreData updated 2026-09-18.